Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment
- 26 May 2024
- journal article
- research article
- Published by Elsevier in Nitric Oxide
- Vol. 149, 7-17
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Association de Recherche sur la Polyarthrite
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- FAPESP (2018/19523-7, 2023/05739-6)
This publication has 96 references indexed in Scilit:
- Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell diseaseJournal of Clinical Laboratory Analysis, 2020
- Riociguat: A Novel New Drug for Treatment of Pulmonary HypertensionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Genetic modifiers of sickle cell diseaseAmerican Journal of Hematology, 2012
- N-acetylcysteine reduces oxidative stress in sickle cell patientsAnnals of Hematology, 2012
- Sickle cell anemia and vascular dysfunction: The nitric oxide connectionJournal of Cellular Physiology, 2010
- Pro-oxidant and anti-oxidant status in patients of sickle cell anaemiaIndian Journal of Clinical Biochemistry, 2004
- Vasoactive factors in sickle cell disease: In vitro evidence for endothelin‐1‐mediated vasoconstrictionAmerican Journal of Hematology, 2004
- Oral L-glutamine therapy for sickle cell anemia: I. subjective clinical improvement and favorable change in red cell NAD redox potentialAmerican Journal of Hematology, 1998
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- PECULIAR ELONGATED AND SICKLE-SHAPED RED BLOOD CORPUSCLES IN A CASE OF SEVERE ANEMIAArchives of internal medicine (1960), 1910